I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fenk, R.
42
results:
Search for persons
X
Format
Online (42)
Mediatypes
E-Books (1)
Articles (Online) (19)
Bookchapter (Online) (2)
OpenAccess-fulltext (20)
Languages
german (4)
english (30)
Sorted by: Relevance
Sorted by: Year
?
1
P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASON..:
Mai, E. K.
;
Bertsch, U.
;
Fenk, R.
...
HemaSphere. 6 (2022) - p. 820-821 , 2022
Link:
https://doi.org/10.1097/..
?
2
Therapy-related myeloid neoplasms following treatment for m..:
Boquoi, A.
;
Banahan, S. M.
;
Mohring, A.
...
Annals of Hematology. 101 (2022) 5 - p. 1031-1038 , 2022
Link:
https://doi.org/10.1007/..
?
3
Aktuelle Entwicklungen in der interdisziplinären Krebsthera..:
, In:
Neues aus Wissenschaft und Lehre der Heinrich-Heine-Universität Düsseldorf 2010
,
Roth, S.
;
Albers, P.
;
Budach, W.
... - p. 111-140 , 2021
Link:
https://doi.org/10.1515/..
?
4
121 PERIPHERAL BLOOD (PB) WILMS' TUMOR 1 (WT1) EXPRESSION Q..:
Schroeder, T.
;
Pechtel, S.
;
Lamers, M.
...
Leukemia Research. 39 (2015) - p. S62-S63 , 2015
Link:
https://doi.org/10.1016/..
?
5
P-210 Azacitidine and DLI as salvage therapy for MDS or AML..:
Schroeder, T.
;
Lamers, M.
;
Fröbel, J.
...
Leukemia Research. 37 (2013) - p. S118 , 2013
Link:
https://doi.org/10.1016/..
?
6
P-230 MDS-derived mesenchymal stromal cells are phenotypica..:
Geyh, S.
;
Cadeddu, R.P.
;
Fröbel, J.
...
Leukemia Research. 37 (2013) - p. S127 , 2013
Link:
https://doi.org/10.1016/..
?
7
Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte I..:
Schroeder, T.
;
Czibere, A.G.
;
Kröger, N.
...
Biology of Blood and Marrow Transplantation. 17 (2011) 2 - p. S159 , 2011
Link:
https://doi.org/10.1016/..
?
8
Bendamustine in patients with relapsed or refractory multip..:
Michael, M
;
Bruns, I
;
Bölke, E
...
European Journal of Medical Research. 15 (2010) 1 - p. 13 , 2010
Link:
https://doi.org/10.1186/..
?
9
Radiotherapie von Weichteilsarkomen: Wertigkeit der Bestrah..:
Bölke, E.
;
Orth, K.
;
Peiper, M.
...
Der Onkologe. 15 (2009) 4 - p. 398-403 , 2009
Link:
https://doi.org/10.1007/..
?
10
Sorafenib (Nexavar®) induces molecular remission and regres..:
Safaian, N.N.
;
Czibere, A.
;
Bruns, I.
...
Leukemia Research. 33 (2009) 2 - p. 348-350 , 2009
Link:
https://doi.org/10.1016/..
?
11
Seltene Vaskulitiden als Hinweis auf Plasmozytom:
Marini, A.
;
Fenk, R.
;
Plettenberg, H.
...
Der Hautarzt. 57 (2006) 2 - p. 137-143 , 2006
Link:
https://doi.org/10.1007/..
?
12
Hairy cell leukemia (HCL) with extensive myelofibrosis resp..:
Strupp, C.
;
Fenk, R.
;
Kündgen, A.
...
Leukemia Research. 29 (2005) 8 - p. 967-969 , 2005
Link:
https://doi.org/10.1016/..
?
13
High‐dose idarubicin, cyclophosphamide and melphalan as con..:
Fenk, R.
;
Schneider, P.
;
Kropff, M.
...
British Journal of Haematology. 130 (2005) 4 - p. 588-594 , 2005
Link:
https://doi.org/10.1111/..
?
14
Transplantation of allogeneic CD34+-selected cells followed..:
Kobbe, G.
;
Fenk, R.
;
Neumann, F.
...
Cytotherapy. 6 (2004) 6 - p. 533-542 , 2004
Link:
https://doi.org/10.1080/..
?
15
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethas..:
Dimopoulos, MA
;
Schjesvold, F
;
Doronin, V
...
issn:2044-5385. , 2022
Link:
http://hdl.handle.net/11..
1-15